Iraq vs Italy: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Iraq
82.0%
in 2025
Italy
82.0%
in 2025
Iraq rank
104th
Italy rank
104th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Iraq
- Italy
How they compare
Iraq currently reports 82.0% against 82.0% in Italy, a difference of 0.0%.
Across all 18 years both countries report, Italy has been ahead every year.
Iraq ranks 104th and Italy ranks 104th of 192 countries.
Italy has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 63.0% | 63.0% | Italy |
| 2010s | 10.3% | 85.5% | 75.2% | Italy |
| 2020s | 26.8% | 89.7% | 62.8% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Iraq or Italy?
- Iraq, at 82.0% against 82.0% in Italy as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Iraq and Italy?
- 0.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Italy?
- 18 years are reported by both, from 2008 to 2025.
- How do Iraq and Italy rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Iraq ranks 104th and Italy ranks 104th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.